A phase I trial of the safety, tolerance, and pharmacokinetics of oral ritonavir co-administered with lamivudine (3TC) and zidovudine (ZDV) [lamivudine/zidovudine] in HIV-1-infected pregnant women and their infants
Phase of Trial: Phase I
Latest Information Update: 13 Mar 2006
At a glance
- Drugs Lamivudine/zidovudine (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 22 Oct 2005 New trial record.